FDA Law Blog

FEBRUARY 13, 2025

The final guidance hasnt changed much from the draft guidance with respect to the type of modifications FDA considers applicable for a PCCP and the required components of a PCCP (see our prior blog post on the draft guidance here ).

Manufacturing 71

Manufacturing Management Specialization Provider 71

FDA Law Blog

MARCH 7, 2024

Led by Annie Kennedy, Everylife’s VP of Government Affairs and Policy, we worked the halls of Congress to educate lawmakers on the pressing needs of the rare disease community. I currently serve as Vice Chair of the Board of the Everylife Foundation. Last Wednesday, the White House hosted its first ever rare disease event.

Government 69

Government Community Specialization Education 69

FDA Law Blog

MARCH 9, 2023

Attorney’s Offices, and, importantly for readers of this blog, the Civil Division’s Consumer Protection Branch (CPB), will all consistently reward corporations that voluntarily disclose and remediate misconduct. It relies on the Department of Justice to do so, either in the form of CPB or in individual U.S.

Government 52

Government Provider IT Individual 52

FDA Law Blog

FEBRUARY 18, 2025

The discussion of the Agencys expectations of the form and substance of expert witness testimony is a must-read for entities or individuals facing a DEA order to show cause hearing. Notably, this discussion does not cite any prior Agency precedent governing expert testimony standards. In Neumanns Pharmacy, LLC , 90 Fed.

Government 69

Government Specialization Patients IT 69

FDA Law Blog

MAY 19, 2025

For a controlled substance prescription to be effective, that is valid, it must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of their professional practice. Attorneys Office, Northern District of Illinois, April 21, 2025. 81, 86, 251. 81, 89, 251.

Individual 64

Individual Patients Provider Medical 64

FDA Law Blog

AUGUST 4, 2022

The approval process, pre-approval concerns, product labeling, clinical trials, adverse events reports, patent concerns, and exclusivity – these are all critical aspects in the commercialization process for drugs and biologics that are governed by the FDA. UNDERSTAND the importance of cGMPs to the post-approval regulatory process.

Government 40

Government Clinic Individual Provider 40

FDA Law Blog

APRIL 10, 2025

federal law enacted in 1967 to promote transparency and accountability in the federal government by granting the public the right to request access to government records, subject to certain exemptions. FOIA is a U.S.

Government 59

Government Provider Community Individual 59

FDA Law Blog

MAY 25, 2023

Director, Anne Walsh , will moderate a panel that addresses what companies should consider when in the crosshairs of a government investigation.

Government 45

Government Healthcare Individual 45

FDA Law Blog

JANUARY 6, 2022

220 and was described on HP&M’s blog here. C) the amount billed to or received from, in part or in whole, the health care benefit program from the individuals referred to a particular recovery home, clinical treatment facility, or laboratory. EKRA is codified at 18 U.S.C. § 18 U.S.C. § 24(b) (emphasis added). 18 U.S.C. §

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

JANUARY 31, 2022

In addition, the Complaint alleges inappropriate dispensing to numerous individuals, multiple DEA recordkeeping violations, improper alteration of prescriptions, and violations Texas law and federal corresponding responsibility obligations required of pharmacists that dispense opioid prescriptions.

Government 40

Government IT Provider Healthcare 40

FDA Law Blog

OCTOBER 13, 2024

Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.

Government 64

Government IT Education Individual 64

FDA Law Blog

NOVEMBER 6, 2022

Gaulkin — We previously blogged about Pfizer’s copay assistance lawsuit, which sought to challenge HHS’s interpretation of the Federal health care program anti-kickback statute (AKS) and position that the company’s proposed copay assistance program would violate the AKS. By Sophia R.

Manufacturing 83

Manufacturing Patient-Centered Healthcare Utilities 83

FDA Law Blog

JUNE 12, 2023

PFI expressed some of its frustration with the current state of regulation of pet food by individual states in its comments on the Center for Veterinary Medicine (CVM) Virtual Public Meeting FDA and the AAFCO Animal Feed Ingredient Definition Process. PFI has noted that it is not feasible to develop and label products for an individual state.

Manufacturing 45

Manufacturing Individual Government Illness 45

FDA Law Blog

MARCH 5, 2024

According to AstraZeneca, the statute defines a qualifying single source drug by reference to its individual “approval,” and “any other reading. According to the court, AstraZeneca’s “desire” or even “expectation” to sell its drugs to the Government at the higher prices it once enjoyed does not create a protected property interest.”

Government 64

Government IT Manufacturing Illness 64

FDA Law Blog

MAY 7, 2025

Two recent cases from the Fifth and Seventh Circuits, however, support the legality of these arrangements in the absence of the government proving certain circumstances. Mallory , 988 F.3d 3d 730 (4th Cir. The case law on commission-based marketing agentsincluding the Sorensen decisionfollow in a similar vein. Marchetti , 96 F.4th

Referral 59

Referral Relationship Government Healthcare 59

FDA Law Blog

JANUARY 6, 2022

220 and was described on HP&M’s blog here. C) the amount billed to or received from, in part or in whole, the health care benefit program from the individuals referred to a particular recovery home, clinical treatment facility, or laboratory. EKRA is codified at 18 U.S.C. § 18 U.S.C. § 24(b) (emphasis added). 18 U.S.C. §

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

FDA Law Blog

AUGUST 8, 2024

Governors, state cannabis regulators, law enforcement groups and local governments weighed in, as did marijuana advocates and opponents, marijuana industry associations, Members of Congress, federal law enforcement groups, healthcare and human rights groups, unions and trade associations, and private individuals. 21 U.S.C. §

Government 59

Government Medical IT Manufacturing 59

FDA Law Blog

JANUARY 31, 2023

Investors who back this kind of longshot research when many others would say “smart money” should go where the biggest markets are.

Patients 59

Patients Patient-Centered Government IT 59

FDA Law Blog

NOVEMBER 6, 2023

Our knowledge of the laws and regulations governing drugs, medical devices, foods, dietary supplements, and cosmetics is unparalleled in breadth and depth. Due to our broad bench of expertise, the firm is well equipped to defend companies against government enforcement actions and advise clients on necessary compliance efforts.

Government 40

Government Provider Medical Individual 40

FDA Law Blog

FEBRUARY 27, 2023

In an erratum filed to the deposition of an official previously self-identified as the Chief FOIA Officer, the government stated that the individual was in fact, not the Chief FOIA Officer for DEA but Chief of the FOIA/PA Unit at DEA. Merrick Garland, et. al , Case No. 4:2022-cv-02396 S.D.

Manufacturing 45

Manufacturing Government Individual IT 45

FDA Law Blog

JUNE 27, 2024

The Government alleged that Coconut Grove violated numerous federal and state controlled substance laws. By Larry K. District Court for the District of Texas on Zarzamora Healthcare LLC for repeatedly dispensing opioids and other controlled substances “by filling prescriptions while ignoring red flags.” 21 U.S.C. § 823(g)(1)(B), (D).

Insurance 52

Insurance Patients Utilities Chronic Condition 52

FDA Law Blog

OCTOBER 10, 2022

You can find our preliminary blog post on the release of this guidance here , and our blog posts on the draft CDS guidances here and here. Specifically, the guidance interprets the Cures Act’s four criteria for exclusion of CDS software functions from FDA’s medical device jurisdiction (so-called “Non-Device CDS”).

Clinic 52

Clinic Medical Provider Patients 52

FDA Law Blog

SEPTEMBER 6, 2022

Although a sponsor of an individual patient expanded access trial may only recover direct costs associated with making the drug available, a sponsor of an intermediate-size patient population expanded access IND, or a treatment IND may also recover administrative costs directly associated with the expanded access use.

Clinic 52

Clinic Manufacturing Patients IT 52

FDA Law Blog

NOVEMBER 2, 2023

These standards would be developed outside the Federal government, leveraging the expertise of the private sector. In short, Voluntary Consensus Standards (VCS) are intended to be exactly what the name conveys – standards that are adopted by consensus and are not mandatory (not legal or regulatory requirements).

Provider 59

Provider Screening IT Government 59

FDA Law Blog

JUNE 16, 2023

The statute confuses the issue by providing that “every individual transaction in violation of [the excessive price increase prohibition] is considered a separate violation,” making it unclear whether this is a per-day or per-transaction penalty, and, if the latter, what the transaction is.

Manufacturing 45

Manufacturing Provider Consulting IT 45

ABIM

JUNE 11, 2025

Visit the ABIM Blog for reports of prior meetings. Community Practice in ABIM Governance* Erica N. She also sought input on overlapping aspects of community practice across the disciplines of internal medicine to inform ABIM’s recruitment efforts for broad physician representation in governance roles.

Board-Certified 52

Board-Certified Government Community Education 52

The Clinical Problem Solvers

OCTOBER 11, 2021

individual bias or bigotry that leads to a failure to sell a home to a person of color) and personal choices ( e.g. Black people prefer to live among other Black people) is referred to as de facto segregation. These gaps are not a product of lifestyle choices, biology or individual behaviors. Richard Rothstein References Rothstein, R.

Government 52

Government Community Education Individual 52

ABIM

JUNE 24, 2025

Visit the ABIM Blog for reports of prior meetings. Community Practice in ABIM Governance* Erica N. She also sought input on overlapping aspects of community practice across the disciplines of internal medicine to inform ABIM’s recruitment efforts for broad physician representation in governance roles.

Board-Certified 40

Board-Certified Board-Certified Physicians Government Community 40

FDA Law Blog

NOVEMBER 14, 2021

But like James Bond, companies in the crosshairs of a government investigation have No Time to Die, as they answer to shareholders and fight for corporate survival. To receive such consideration, companies cannot limit disclosure to those individuals believed to be only substantially involved in the criminal conduct.

Individual 52

Individual Government Provider IT 52

FDA Law Blog

FEBRUARY 7, 2024

Gilbert — Last week, DEA and DOJ announced a $59 million civil penalty settlement with eBay related to the failure to comply with Controlled Substances Act (CSA) requirements for identifying purchasers, maintaining records, and filing reports of individuals selling/purchasing pill presses and encapsulating machines.

Government 116

Government Electronics Education Individual 116

FDA Law Blog

NOVEMBER 18, 2021

The tests are very accurate in detecting individuals with a relatively high viral load (symptomatic or not). On the minus side, a rapid antigen test may miss an infected individual with a low viral load (e.g., A follow up laboratory?run run molecular diagnostic (RT?PCR) PCR) test is considered the gold standard for actual diagnosis.

Screening 98

Screening Healthcare IT Manufacturing 98

FDA Law Blog

MARCH 15, 2023

See Government Accountability Office, “ GAO-06-724 Mammography: Current Nationwide Capacity Is Adequate, but Access Problems May Exist in Certain Locations ” (July 2006). Talk to your healthcare provider about breast density, risks for breast cancer, and your individual situation.” Your breast tissue is not dense.

Healthcare 59

Healthcare Diagnosis Provider Individual 59

FDA Law Blog

APRIL 8, 2024

What about government factors that cause drug shortages? What the White Paper does not adequately address is whether there are any government-controlled factors that also cause drug shortages. On August 10, FDA requested that DEA increase the APQ and individual manufacturing quotas to address the shortage. Section I.C

Supply Chain 59

Supply Chain Manufacturing Government Hospital 59

FDA Law Blog

OCTOBER 17, 2023

In October 2022, FDA released the draft guidance entitled “Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Healthcare,” as previously discussed in our blog. FDA will consider if technologies and device features “address unmet needs in these populations” when evaluating criterion one.

Medical 53

Medical Diagnosis Healthcare Clinic 53

FDA Law Blog

FEBRUARY 9, 2022

DEA regulations state that a pharmacist has a corresponding responsibility not to fill a prescription unless it is issued for a “legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” The Administrator found that Gulf Med failed to resolve this red flag. at 72,730.

IT 40

IT Insurance Government Patients 40

FDA Law Blog

JUNE 2, 2023

Kirschenbaum — Last Friday, May 26, CMS published in the Federal Register an assortment of proposals to change the regulations governing the Medicaid Drug Rebate Program. Best Price Stacking We previously blogged about the 4 th Circuit Court of Appeals decision in United States Ex Rel. Sheldon, v.

Manufacturing 59

Manufacturing Vaccination Government Diagnosis 59

GeriPal

JANUARY 11, 2024

The last time we had you on the podcast, Bill, you talked about your cancer diagnosis and a personal experience with MAID, which you also, we’ll have a link to your blog post too about this as well. So it started off for individuals with a terminal illness. Eric: Well, I wonder if we can contextualize this.

Illness 144

Illness IT Medical Provider 144